Postbiotic ingredient market seen reaching $2.02 billion by 2030

The global postbiotic ingredient market is projected to grow from $1.2 billion in 2025 to $2.02 billion by 2030, driven by preventive healthcare demand, gut health awareness and microbiome research. North America leads today, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - The postbiotic ingredient market is moving from a niche wellness category into a broader nutrition and health segment. - Growth reflects rising consumer demand for gut health, immune support and stable non-living alternatives to probiotics. - The market’s expansion also signals more investment in microbiome research, personalized nutrition and functional foods.

What happened: - The Business Research Company projected the global postbiotic ingredient market will rise from $1.2 billion in 2025 to $1.33 billion in 2026. - The forecast puts the market at $2.02 billion by 2030. - The projected 2025-2026 CAGR is 10.9%. - The projected 2026-2030 CAGR is 11.1%. - The company released the market outlook on July 6, 2026. - The report covers regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - The source includes a free sample report and the full market report.

The details: - Postbiotic ingredients are bioactive substances produced by probiotic microorganisms during fermentation. - The category includes metabolites, cell fragments and byproducts. - Postbiotics do not require live microorganisms to be effective. - Their functions include supporting gut health, immune performance and overall wellness. - The historical growth has been tied to awareness of gut health benefits, wider probiotic use, higher functional food consumption, growth in dietary supplements and microbiome research. - Future growth is linked to demand for immune-boosting products, more lifestyle-related disorders, preventive healthcare through nutrition, personalized nutrition and microbiome-focused R&D. - The company highlighted clean-label and natural postbiotic formulations, tailored gut health products, fermentation-derived bioactive compounds, microbiome-targeted pharmaceuticals and stable probiotic alternatives as key trends. - The report also says market reports now include market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables.

Between the lines: - Preventive healthcare is becoming a larger buying trigger for ingredients tied to immunity and metabolic health. - The OECD’s Health at a Glance 2025 found preventive care accounted for about 3% of total health expenditure across OECD countries, suggesting room for more spending in this area. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

What's next: - The market is likely to keep benefiting from microbiome science, clean-label product development and demand for shelf-stable functional ingredients. - Growth in personalized nutrition and gut-health products could widen postbiotic use across food, beverage, supplement and pharmaceutical categories. - The company said the 2026 edition of its reports adds stronger forecasting and regional analysis, which may help buyers and investors track where demand is building.